CAPITOL HILL CONSULTING GROUP for ELI LILLY AND COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General Medicare and Medicaid issues pertaining to Eli Lilly and Company. including but not limited to, coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Health Issues HCR
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug importation
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Government Issues GOV
general patent issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Taxation/Internal Revenue Code TAX
General tax issues pertaining to Eli Lilly and Company
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Pharmacy PHA
General Pharmaceutical issues pertaining to Eli Lilly and Company, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; and drug importation
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.